Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
cartilage thickness measurement	EFO_0007873	[Quantification of the thickness of cartilage in a joint, most commonly the hip joint, for example using minimal joint space width (mJSW) as a proxy measure. Cartilage thickness is an indicator of joint health, which makes it a suitable biomarker for osteoarthritis.]
brain connectivity measurement	EFO_0005210	[quantification of the pattern of links between distinct units within a nervous system through neuroimaging techniques such a MRI]
obsolete_qualitative or quantitative defects of calpain	Orphanet_207104
aspirin hydrolysis measurement	EFO_0005211	[quantification of the rate of hydrolysis of aspirin in blood as an indicator of the therapeutic effectiveness of aspirin]
caffeine metabolite measurement	EFO_0007872	[quantification of caffeine (1,3,7 trimethylxanthine) or any metabolite derived from caffeine, including paraxanthine (1,7 dimethylxanthine), theophylline (1,3 dimethylxanthine), and theobromine (3,7 dimethylxanthine) in a sample]
tyrosine-protein phosphatase non-receptor type 11 measurement	EFO_0020835	[The determination of the amount of tyrosine-protein phosphatase non-receptor type 11 in a sample]
petaloid toenail	EFO_0007879	[physical trait of the small toe, where a minuscule "sixth toenail" is present in the outer corner of the nail situated on the smallest toe]
Abnormal toenail morphology	HP_0008388	[An anomaly of the toenail.]
tyrosine-protein phosphatase non-receptor type 2 measurement	EFO_0020836	[The determination of the amount of tyrosine-protein phosphatase non-receptor type 2 in a sample]
tyrosine-protein phosphatase non-receptor type 6 measurement	EFO_0020837	[The determination of the amount of tyrosine-protein phosphatase non-receptor type 6 in a sample]
risky sexual behaviour measurement	EFO_0007877	[quantification of some aspect of risky sexual behaviour such as frequency of unprotected sexual intercourse and number of sexual partners within a given time frame]
behavioural disinhibition measurement	EFO_0006946	[quantification of some aspect of behavioural disinhibition, including risky and impulsive behaviours. Behavioural disinhibition can be a marker for certain kinds of mental or behavioural disorders.]
ubiquitin carboxyl-terminal hydrolase isozyme L1 measurement	EFO_0020838	[The determination of the amount of ubiquitin carboxyl-terminal hydrolase isozyme L1 in a sample]
insomnia measurement	EFO_0007876	[quantification of insomnia such as how often it occurs and its severity]
tyrosine-protein kinase transmembrane receptor ROR1 measurement	EFO_0020831	[The determination of the amount of tyrosine-protein kinase transmembrane receptor ROR1 in a sample]
tyrosine-protein kinase YES measurement	EFO_0020832	[The determination of the amount of tyrosine-protein kinase YES in a sample]
tyrosine-protein kinase ZAP-70 measurement	EFO_0020833	[The determination of the amount of tyrosine-protein kinase ZAP-70 in a sample]
cervical cancer cell line	BTO_0001967
tyrosine-protein phosphatase non-receptor type 1 measurement	EFO_0020834	[The determination of the amount of tyrosine-protein phosphatase non-receptor type 1 in a sample]
TraDIS sequencing	EFO_0005219	[Tra-DIS or Transposon Directed Insertion Site Sequencing is a sequencing technology developed at the Sanger Institute. The technique involves insertingtransposons into the genome to generate large numbers of mutants.]